Immunocore Holdings Ltd (IMCR) — Capital Reinvestment Ratio
Immunocore Holdings Ltd (IMCR) has a Capital Reinvestment Ratio of 0.02x as of June 2025, meaning it reinvests 0% of its operating cash flow ($25.96 Million) in capital expenditures ($414.00K). Check IMCR intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Immunocore Holdings Ltd Capital Reinvestment Ratio (2023–2024)
This chart tracks Immunocore Holdings Ltd's Capital Reinvestment Ratio across 2 annual periods. For the full cash flow conversion analysis, see IMCR cash flow metrics.
Annual Capital Reinvestment Ratio for Immunocore Holdings Ltd (2023–2024)
Year-by-year Capital Reinvestment Ratio for Immunocore Holdings Ltd from 2023 to 2024. See cash generation quality of Immunocore Holdings Ltd to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.20x | $26.06 Million | $5.17 Million | ▼ -89.2% |
| 2023 | 1.85x | $2.94 Million | $5.42 Million | — |